NCT03423927 is a NA clinical trial of Self-hypnosis + Self-care in Prostate Cancer, sponsored by University of Liege.

Who is sponsoring NCT03423927?

NCT03423927 is sponsored by University of Liege.

What drugs are being tested in NCT03423927?

Interventions in NCT03423927: Self-hypnosis + Self-care.

What condition does NCT03423927 study?

NCT03423927 studies Prostate Cancer.

Is NCT03423927 still recruiting?

NCT03423927 is currently completed. Last updated 6 February 2018.

Last reviewed 2018-02-06 · How we verify

NCT03423927

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer Patients

Completed NA Last updated 6 February 2018

What this trial tests

NA trial testing Self-hypnosis + Self-care in Prostate Cancer in 46 participants. Completed in 15 June 2016.

Timeline

14 October 2013

Primary endpoint
15 June 2016

15 June 2016

Quick facts

Lead sponsor	University of Liege
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	46
Start date	14 October 2013
Primary completion	15 June 2016
Estimated completion	15 June 2016

Drugs / interventions tested

Self-hypnosis + Self-care

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

University of Liege

Who can join

18 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the impact of a group intervention combining self-hypnosis and self-care techniques on prostate patients' well-being. More specifically, the investigators want to investigate the effects of that intervention on sleep, fatigue and emotional distress of the patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients.
Grégoire C, Nicolas H, Bragard I, Delevallez F, et al · · 2018 · cited 19× · PMID 29929493 · DOI 10.1186/s12885-018-4607-z

Verify or expand the search:

Other trials of Self-hypnosis + Self-care

Trials testing the same drug.

NCT03144154 — Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners · NA · completed

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03423927 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 6 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03423927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing